ÂÜÀòÂÒÂ×

The Research and Development team at Affinia Therapeutics focuses on the design, evaluation, and optimization of gene therapies aimed at treating severe diseases. This multidisciplinary group of scientists and research associates engages in key activities, including vector development, bioanalytical characterization, and in vivo studies, to ensure the efficacy and safety of innovative therapeutic solutions. Leveraging computational biology and advanced process development techniques, the team drives forward the discovery and translation of novel gene therapies into actionable treatments.